a group of 122 postmenopausal patients with histologically proven node-positive primary breast cancer have been randomized to receive aminoglutethimide-hydrocortisone or placebo aminoglutethimide-placebo hydrocortisone for 2 years .
C0392969
aminoglutethimide-hydrocortisone
C0002555
aminoglutethimide